Create account / Login
Score: n/a SD: (n/a)

Open Statement: Interleukin 1

Subgroup: other

Posted by Thomas Maurer

  Title Author Journal Year Paper
level
(mean)
Readers
vote
(mean)
Number of
Voters
 
1 Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL. Sengupta, Dola; Koblansky, Alicia; Gaines, Jennifer; Brown, Tim; West, A Phillip; Zhang, Dekai; Nishikawa, Tak; Park, Sung-Gyoo; Roop, R Martin; Ghosh, Sankar; Journal of immunology (Baltimore, Md. : 1950) 2010 0.00 0.00 0
2 A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil. Jesus, Adriana A; Osman, Mazen; Silva, Clovis A; Kim, Peter W; Pham, Tuyet-Hang; Gadina, Massimo; Yang, Barbara; Bertola, Débora R; Carneiro-Sampaio, Magda; Ferguson, Polly J; Renshaw, Blair R; Schooley, Ken; Brown, Michael; Al-Dosari, Asma; Al-Alam Arthritis and rheumatism 2011 0.00 0.00 0
3 The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist. Stenerson, Matthew; Dufendach, Kevin; Aksentijevich, Ivona; Brady, Jillian; Austin, Jared; Reed, Ann M; Arthritis and rheumatism 2011 0.00 0.00 0
4 Alendronate regulates cytokine production induced by lipid A through nuclear factor-?B and Smad3 activation in human gingival fibroblasts. Tamai, R; Sugiyama, A; Kiyoura, Y; Journal of periodontal research 2011 0.00 0.00 0

Back to questionlist